Drug intelligence / Profile preview

RAB7 siRNA

Development stage
Preclinical
Lead developer
The Ohio State University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Parenteral
01

Overview

RAB7 siRNA is a small interfering RNA designed to silence the expression of the RAB7 gene, which encodes an endosomal GTPase involved in endocytic trafficking and lysosomal biogenesis. In the context of pulmonary arterial hypertension (PAH) research, RAB7 siRNA is utilized as a laboratory tool to model the deficiency of RAB7 observed in the pulmonary artery endothelial cells (PAECs) of patients. Silencing RAB7 in PAECs leads to endothelial dysfunction, senescence, and an altered secretome that promotes the aberrant proliferation and phenotypic shifting of smooth muscle cells and adventitia fibroblasts. This research tool has been instrumental in identifying downstream effectors, such as the RNA-binding protein CSDE1, which regulates the endothelial secretome under conditions of RAB7 deficiency.

Other names
RAB7 small interfering RNARAB-7 small interfering RNARAB 7 small interfering RNAsiRNA targeting RAB7
02

Targets

RAB7A

Beyond the preview

Go deeper on RAB7 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB7 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call